PEAK PERFORMANCEWeeks to result

Phosphodidal Serine for ADHD

Phospholipid for focus

Problem it solves

Individuals and organizations that struggle with phosphodidal serine for adhd, lacking a clear and actionable framework to diagnose root causes and take systematic improvement steps.

Best for

Individuals with ADHD or attention deficits

Not ideal for

Those with underlying psychiatric or mood disorders

Overview

Why this framework exists

Phosphodidal serine is a phospholipid that has been shown to improve symptoms of ADHD in children. It has been found to have synergistic effects with omega-3 fatty acids.

Core principles

3 total
  1. Phosphodidal serine can improve symptoms of ADHD in children.
  2. It has synergistic effects with omega-3 fatty acids.
  3. Phosphodidal serine may be used in conjunction with other treatments, such as behavioral exercises, for enhanced effects.

Steps

1 steps
  1. Choose a phosphodidal serine supplement
    Select a phosphodidal serine supplement that is certified by a third-party organization.
    Pro tipLook for a supplement that contains a sufficient amount of phosphodidal serine (at least 200 mg per day).
    WarningBe aware of potential interactions with other medications.

Checklist

Saved in your browser

Examples

1 cases
Case study: Phosphodidal serine for ADHD

A study found that children with ADHD who took a phosphodidal serine supplement containing 200 mg per day showed significant improvements in attention and focus.

OutcomeImproved attention and focus in children with ADHD.

Common mistakes

1 traps
Insufficient dosage
Taking too little phosphodidal serine (less than 200 mg per day) may not produce significant effects.

Origin story

How this framework came to be

Research on phosphodidal serine and its effects on ADHD has been ongoing for several years. Studies have consistently shown that it can improve attention and focus in children with ADHD.

Source

Traced to primary
Source · PODCAST
ADHD & How Anyone Can Improve Their Focus | Huberman Lab Essentials
Andrew Huberman · 2025
Open source →